Preimplantation Genetic Screening is a sophisticated genetic testing procedure performed during in vitro fertilization (IVF) that allows for:
-
Comprehensive chromosomal analysis of embryos
-
Detection of genetic abnormalities
-
Embryo sex determination
-
Selection of the healthiest embryos for transfer
Key Applications
-
Screening for chromosomal abnormalities (aneuploidy screening)
-
Identification of specific genetic disorders
-
Family balancing through sex selection
-
Improving IVF success rates
The PGS Process
-
Embryo Biopsy: Removal of 5-10 cells from the trophectoderm (day 5-6 blastocyst)
-
Genetic Analysis:
-
Chromosomal screening (24-chromosome analysis)
-
Specific gene mutation testing (when indicated)
-
-
Embryo Selection:
-
Identification of genetically normal embryos
-
Optional gender selection
-
-
Embryo Transfer: Implantation of selected embryos
Who Benefits from PGS?
✓ Couples with family history of genetic disorders
✓ Women of advanced maternal age (35+)
✓ Couples with recurrent pregnancy loss
✓ Those with previous IVF failures
✓ Families seeking gender balance
Technical Advantages
-
Next-generation sequencing (NGS) technology
-
99% accuracy in chromosomal analysis
-
Reduced risk of genetic disorders
-
Increased implantation rates (up to 70% improvement)
-
Lower miscarriage rates
Ethical Considerations
-
Gender selection regulations vary by country
-
Counselling required for informed decision-making
-
Storage and disposition of unused embryos
-
Limitations in detecting all genetic conditions
Clinical Outcomes
-
Significantly higher live birth rates per transfer
-
Reduced time to successful pregnancy
-
Lower risk of chromosomal conditions (e.g., Down syndrome)
-
Ability to screen for single gene disorders (when combined with PGD)
PGS vs. PGD
While PGS screens for chromosomal abnormalities, Preimplantation Genetic Diagnosis (PGD) tests for specific genetic diseases. Many clinics now combine these approaches for comprehensive genetic assessment.
Future Directions
-
Expanded carrier screening
-
Whole genome sequencing
-
Non-invasive embryo testing development
-
Improved aneuploidy prediction models
